Testing is a crucial component of our global response to COVID-19. The more people we can test for the virus, the better we can understand the threat we’re up against.
Read More
COVID-19: 7 Steps to plan for re-entering the workplace
The COVID-19 pandemic has presented new challenges and created questions about what life in the office will look like going forward.
Read More
The basics and the process of drug approval
The COVID-19 pandemic has put the spotlight on the FDA drug approval process. Why will it take so long for a vaccine to get approved?
Read More
During a crisis, moving drugs to market requires a strong HVAC strategy
As the global pandemic brings new attention to emerging therapies, the biopharmaceutical industry shouldn’t overlook HVAC design for contamination control.
Read More
6 considerations for scaling up an industrial biotechnology process
Industrial biotechnology processes face a unique set of challenges when it comes to scale-up.
Read More
Preventing the next pandemic: mRNA vaccines and siRNA oligo therapies
Investing in promising new pharmaceutical platforms like oligonucleotide therapies could reduce the gap between first detection and total eradication in future pandemics.
Read More
4 strategies of successful project execution
A lean approach to project execution relies on four steps for success.
Read More
Developing new tools in the pandemic response toolbox
There’s a lot to be learned from the COVID-19 pandemic, including how we can be better prepared for future pandemics.
Read More
Viral vectors—beyond the yellow brick road
The science of viral vector manufacturing is generating a lot of excitement, and companies in this space are under pressure to move fast and make cost-effective decisions; this can occasionally result in speed at the expense of due diligence.
Read More
Vaccines—our best long-term defense
Not a treatment, but a cure, vaccines are extremely important because they help us develop lifelong immunity to diseases.
Read More